ATE222366T1 - Immunohistochemischer nachweis des proliferativen zustandes von karzinoma - Google Patents
Immunohistochemischer nachweis des proliferativen zustandes von karzinomaInfo
- Publication number
- ATE222366T1 ATE222366T1 AT97952197T AT97952197T ATE222366T1 AT E222366 T1 ATE222366 T1 AT E222366T1 AT 97952197 T AT97952197 T AT 97952197T AT 97952197 T AT97952197 T AT 97952197T AT E222366 T1 ATE222366 T1 AT E222366T1
- Authority
- AT
- Austria
- Prior art keywords
- carcinoma
- sample
- immunohistochemical detection
- proliferative state
- expression product
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/779,870 US5846739A (en) | 1995-12-05 | 1997-01-06 | Immunohistochemical detection assay for carcinoma proliferative status |
| PCT/US1997/020998 WO1998030907A1 (en) | 1997-01-06 | 1997-11-18 | Immunohistochemical detection assay for carcinoma proliferative status |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE222366T1 true ATE222366T1 (de) | 2002-08-15 |
Family
ID=25117836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97952197T ATE222366T1 (de) | 1997-01-06 | 1997-11-18 | Immunohistochemischer nachweis des proliferativen zustandes von karzinoma |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5846739A (de) |
| EP (1) | EP0958500B1 (de) |
| JP (1) | JP3336016B2 (de) |
| AT (1) | ATE222366T1 (de) |
| AU (1) | AU712949B2 (de) |
| CA (1) | CA2271092C (de) |
| DE (1) | DE69714778T2 (de) |
| DK (1) | DK0958500T3 (de) |
| ES (1) | ES2182140T3 (de) |
| IL (1) | IL129766A (de) |
| NZ (1) | NZ335535A (de) |
| WO (1) | WO1998030907A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6517513B1 (en) * | 1999-01-21 | 2003-02-11 | Neomatrix, Llc | Intraductal breast fluid aspiration device |
| US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| WO2001077682A1 (fr) * | 2000-04-10 | 2001-10-18 | Institut Bioorganicheskoi Khimii Imeni Akademikov M.M. Shemyakina I Ju. A. Ovchinnikova Rossiisskoi Akademii Nauk | Anticorps diriges contre le facteur hldf, procedes de fabrication correspondants, peptides avec des capacites antigeniques et a hydrolyse hk et procede de diagnostic de l'etat anaplasique de cellules humaines |
| US6866994B2 (en) * | 2001-05-30 | 2005-03-15 | Neomatrix, Llc | Noninvasive intraductal fluid diagnostic screen |
| DE10230631A1 (de) * | 2002-07-02 | 2004-01-22 | Metagen Pharmaceuticals Gmbh | Verwendungen von an Ngal bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen |
| CA2602585A1 (en) | 2005-03-30 | 2006-10-05 | Purdue Research Foundation | Method for cancer prognosis using cellular folate vitamin receptor quantification |
| US20100105150A1 (en) * | 2008-10-24 | 2010-04-29 | Abbott Laboratories | Isolated human autoantibodies to neutrophil gelatinase-associated lipocalin (ngal) and methods and kits for the detection of human autoantibodies to ngal |
| JP2012508177A (ja) * | 2008-11-05 | 2012-04-05 | アボット・ラボラトリーズ | 尿および組換えチャイニーズハムスター卵巣（ｃｈｏ）細胞から濃縮された好中球ゼラチナーゼ関連リポカリン（ｎｇａｌ）タンパク質アイソフォーム、ならびに関連する組成物、抗体、ならびに濃縮、分析および使用の方法 |
| US9187567B2 (en) | 2011-05-18 | 2015-11-17 | Parkinson's Institute | Assay to determine LRRK2 activity in parkinson's disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996024065A1 (en) * | 1995-02-03 | 1996-08-08 | Oncogene Science, Inc. | Methods for the detection of pro-cathepsins and uses thereof |
| US5627034A (en) * | 1995-12-05 | 1997-05-06 | Wisconsin Alumni Research Foundation | Assay for carcinoma proliferative status by measuring NGAL expression level |
-
1997
- 1997-01-06 US US08/779,870 patent/US5846739A/en not_active Expired - Fee Related
- 1997-11-18 CA CA002271092A patent/CA2271092C/en not_active Expired - Fee Related
- 1997-11-18 EP EP97952197A patent/EP0958500B1/de not_active Expired - Lifetime
- 1997-11-18 IL IL12976697A patent/IL129766A/en not_active IP Right Cessation
- 1997-11-18 WO PCT/US1997/020998 patent/WO1998030907A1/en active IP Right Grant
- 1997-11-18 AT AT97952197T patent/ATE222366T1/de not_active IP Right Cessation
- 1997-11-18 AU AU55867/98A patent/AU712949B2/en not_active Ceased
- 1997-11-18 DE DE69714778T patent/DE69714778T2/de not_active Expired - Fee Related
- 1997-11-18 JP JP53085298A patent/JP3336016B2/ja not_active Expired - Fee Related
- 1997-11-18 ES ES97952197T patent/ES2182140T3/es not_active Expired - Lifetime
- 1997-11-18 NZ NZ335535A patent/NZ335535A/xx unknown
- 1997-11-18 DK DK97952197T patent/DK0958500T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| JP3336016B2 (ja) | 2002-10-21 |
| DE69714778T2 (de) | 2003-04-10 |
| AU712949B2 (en) | 1999-11-18 |
| CA2271092C (en) | 2004-02-10 |
| IL129766A (en) | 2002-02-10 |
| IL129766A0 (en) | 2000-02-29 |
| DK0958500T3 (da) | 2002-10-07 |
| ES2182140T3 (es) | 2003-03-01 |
| AU5586798A (en) | 1998-08-03 |
| EP0958500A1 (de) | 1999-11-24 |
| JP2000508074A (ja) | 2000-06-27 |
| CA2271092A1 (en) | 1998-07-16 |
| DE69714778D1 (de) | 2002-09-19 |
| EP0958500B1 (de) | 2002-08-14 |
| WO1998030907A1 (en) | 1998-07-16 |
| NZ335535A (en) | 2000-08-25 |
| US5846739A (en) | 1998-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60228684D1 (de) | System zur überwachung der konzentration von analyten in körperflüssigkeiten | |
| ATE328278T1 (de) | Sammelapparat für einschrittigen test von mundflüssigkeiten | |
| ATE312349T1 (de) | Differentielle diagnose von neurodegeneration | |
| DE69838389D1 (de) | Regeneration von biosensoren | |
| NO20010011L (no) | Optisk sensor for in-situ-måling av analytter | |
| DE69716589D1 (de) | Quantitative immunochromatographische assays | |
| AU2004256206A1 (en) | Device and method for simultaneous carrying out of blood group determination, serum cross-check and antibody detection test | |
| CA2530052A1 (en) | System and method for analyte measurement using dose sufficiency electrodes | |
| AU2003243558A8 (en) | Test strip for detection of analyte and methods of use | |
| AU2001272327A1 (en) | Method and device for detecting substances in body fluids by raman spectroscopy | |
| DE50209636D1 (de) | Messvorrichtung und -verfahren zur Bestimmung von Parametern medizinischer Flüssigkeiten | |
| BR9507690A (pt) | Detecção de reticulócitos | |
| DE69330067D1 (de) | Analytische testvorrichtung einschliesslich negativ- und positivkontrolle | |
| DE69729156D1 (de) | Verfahren zum Nachweis von Komplex-gebundenem Prostata-spezifischem Antigen (kPSA) | |
| ATE222366T1 (de) | Immunohistochemischer nachweis des proliferativen zustandes von karzinoma | |
| ATE343134T1 (de) | Detektionsvorrichtung und -verfahren | |
| IL142971A0 (en) | S100 proteins and autoantibodies as serum markers for cancer | |
| DE69636749D1 (de) | Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten | |
| ATE282831T1 (de) | Verfahren zur diagnose von sepsis unter bestimmung löslicher cytokeratinfragmente | |
| EP1563308A4 (de) | Verfahren und kits zur tumorigenizitätsdiagnose | |
| DE69736336D1 (de) | Verfahren zur messung von blutersatzstoffen | |
| DE50103032D1 (de) | Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 19-9 | |
| TW369411B (en) | Disposal electrode test block for current-type non-enzymatic uric acid test, its process and application | |
| DE60320821D1 (de) | ||
| WO1998046993A3 (en) | Method for diagnosing cancer by measuring the presence of creatine kinase inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |